PMS-IRBESARTAN-HCTZ
PHARMASCIENCE INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of PMS-IRBESARTAN-HCTZ in Canada?
Yes. PMS-IRBESARTAN-HCTZ 12.5MG 300MG has an active shortage reported to Health Canada (last updated August 4, 2025).
Why is PMS-IRBESARTAN-HCTZ not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will PMS-IRBESARTAN-HCTZ be available again?
The manufacturer's estimated resolution date is December 1, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-12-01
~2 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02328526
Strength
12.5MG 300MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
HYDROCHLOROTHIAZIDE IRBESARTAN
Tier
Unrated
Last Updated
2025-08-04
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from PHARMASCIENCE INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02303299
DIN 01999648
DIN 01999656
DIN 02028174
DIN 02025337
650MG · DIN 02527901
81MG · DIN 02433044
81MG · DIN 02244993
81MG · DIN 02394790
80MG · DIN 02009013
80MG · DIN 02238545
40MG · DIN 02399393